1. Home
  2. JBSS vs GERN Comparison

JBSS vs GERN Comparison

Compare JBSS & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBSS
  • GERN
  • Stock Information
  • Founded
  • JBSS 1959
  • GERN 1990
  • Country
  • JBSS United States
  • GERN United States
  • Employees
  • JBSS N/A
  • GERN N/A
  • Industry
  • JBSS Specialty Foods
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JBSS Consumer Staples
  • GERN Health Care
  • Exchange
  • JBSS Nasdaq
  • GERN Nasdaq
  • Market Cap
  • JBSS 794.3M
  • GERN 840.7M
  • IPO Year
  • JBSS 1991
  • GERN 1996
  • Fundamental
  • Price
  • JBSS $67.73
  • GERN $1.42
  • Analyst Decision
  • JBSS
  • GERN Buy
  • Analyst Count
  • JBSS 0
  • GERN 11
  • Target Price
  • JBSS N/A
  • GERN $5.80
  • AVG Volume (30 Days)
  • JBSS 65.5K
  • GERN 13.7M
  • Earning Date
  • JBSS 04-30-2025
  • GERN 05-07-2025
  • Dividend Yield
  • JBSS 4.60%
  • GERN N/A
  • EPS Growth
  • JBSS N/A
  • GERN N/A
  • EPS
  • JBSS 4.16
  • GERN N/A
  • Revenue
  • JBSS $1,118,719,000.00
  • GERN $76,994,000.00
  • Revenue This Year
  • JBSS N/A
  • GERN $208.83
  • Revenue Next Year
  • JBSS N/A
  • GERN $57.49
  • P/E Ratio
  • JBSS $16.44
  • GERN N/A
  • Revenue Growth
  • JBSS 12.09
  • GERN 32386.92
  • 52 Week Low
  • JBSS $65.29
  • GERN $1.17
  • 52 Week High
  • JBSS $105.63
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • JBSS 43.36
  • GERN 44.54
  • Support Level
  • JBSS $67.01
  • GERN $1.17
  • Resistance Level
  • JBSS $69.40
  • GERN $1.47
  • Average True Range (ATR)
  • JBSS 2.13
  • GERN 0.12
  • MACD
  • JBSS 0.25
  • GERN 0.04
  • Stochastic Oscillator
  • JBSS 55.71
  • GERN 83.33

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: